To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
81 Current news about the topic calcium
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Ecka Granules acquires MicroMet GmbH Pulvertechnologie
13-Jun-2002
Fürth, 13 June 2002 - Norddeutsche Affinerie AG (NA) has sold its former subsidiary, MicroMet GmbH Pulvertechnologie, to ECKA Granulate GmbH & Co. KG in Fürth/Bavaria. It was agreed that the 100 % acquisition of MicroMet by ECKA will be backdated to 1 April 2002. MicroMet with 69 employees is ...
Agilent Technologies extends boundaries of environmental metals analysis
22-May-2002
Agilent Technologies Inc. announced a system that extends the traditional analytical range for metals in environmental samples in a production laboratory, eliminating the need for other techniques such as graphite furnace atomic absorption and inductively coupled plasma optical emission ...
Calcium fluoride growth in Thuringia successful
06-Mar-2002
Jena, March 4, 2002 - Schott Lithotec, Jena, strengthens its world leadership position in technology, quality and production capacity of calcium fluoride crystals. Crystalline calcium fluoride has assumed a key function for current and future applications in microlithography (193- and 157 nm ...
Schott achieves 6 percent growth in spite of economic downturn
14-Dec-2001
Schott increased its sales in the 2000/2001 fiscal year (to September 30) by 6 percent to more than 2 billion euros (1999/2000: 1.9 billion euros). Economic conditions resulted in a marked fall-off in sales and especially incoming orders during the course of the year. Nevertheless, the ...
Schott Lithotec AG: New production line sets standard for mask blanks
03-Dec-2001
Schott Lithotec AG, Jena, today announced that it put one of the world's most powerful production plants for leading edge mask blanks into operation in Meiningen/Thuringia. Mask blanks serve as the basis for photo masks used for the production of semiconductor chips. With the so-called "Advanced ...
FDA approves Novartis' Zometa for the treatment of hypercalcemia of malignancy
22-Aug-2001
Novartis announced today that it has received marketing approval from the US Food and Drug Administration (FDA) for Zometa 4 mg (zoledronic acid for injection), a new generation intravenous bisphosphonate for the treatment of hypercalcemia of malignancy (HCM). HCM is the most common ...
Schott Lithotec underscores leadership position
07-Aug-2001
Schott Lithotec AG of Jena, Germany, one of the leading manufacturers of optical materials and components for microlithography, continues on its growth trajectory despite the current crisis in the semiconductor industry. As planned, the company's third production facility for calcium fluoride ...
Israelis Turn Human Stem Cells Into Heart Cells
02-Aug-2001
Scientists said on Wednesday that they had grown heart cells from human embryonic stem cells, an important step toward harnessing the transformational qualities of these primitive master cells to regenerate tissue damaged by cardiac disease. Israeli researchers said they had created early-stage ...
New Treatment Guidelines Recommend Bisphosphonates as First-line Therapy for Treatment of Glucocorticoid-Induced Osteoporosis
23-Jul-2001
New treatment guidelines published in the current issue of Arthritis and Rheumatism by the American College of Rheumatology (ACR) recommend bisphosphonates as first-line therapy in conjunction with calcium and vitamin D for preventing and treating glucocorticoid-induced osteoporosis (GIO), ...
First filing for FOZNOL* (lanthanum carbonate) in Europe
15-Mar-2001
Shire Pharmaceuticals Group plc (Nasdaq: SHPGY, LSE: SHP.L) announces that the first regulatory submission for Foznol* (lanthanum carbonate, Project Lambda) was delivered to a Reference Member State in the EU Mutual Recognition Procedure yesterday. Foznol* is being developed for the treatment ...
